Search | Page 36 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate

    ... transplantation with a haploidentical donor peripheral blood stem cell graft depleted of TCRαβ+ cells and CD19+ cells in conjunction with the immunomodulating drug, ...

    Clinical Trial last updated 04/29/2016 - 4:35pm.

  2. Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT

    ... with hematologic malignancies undergoing hematopoietic stem cell transplant (HSCT). Biological therapies, such as sirolimus and ... suppress the immune system in different ways and stop tumor cells from growing. Giving sirolimus and mycophenolate mofetil after ...

    Clinical Trial last updated 05/03/2016 - 11:35am.

  3. Dr. Vivienne Rebel reports on a study of the relationship between gene mutations and overall survival after stem cell transplant

    ... patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation. Original Publication ... isolated from bone marrow or peripheral blood cells from 87 patients prior to undergoing a blood- stem cell transplant ...

    Research Review last updated 05/02/2016 - 9:16am.

  4. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... or partially matched UCB unit with >/= 2.5 x10^7 nucleated cells/kg of recipient weight at the time of cryopreservation. No current ... . Prior allogeneic or autologous hematopoietic stem cell transplant in the last 6 months. Patients who are taking ...

    Clinical Trial last updated 06/06/2016 - 3:37pm.

  5. Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

    ... side effects and best dose of selinexor when given after stem cell transplant in treating patients with acute myeloid leukemia that ... cancer growth by blocking an enzyme, which may cause cancer cells to die and also kill cells that cause the cancer to grow, which commonly ...

    Clinical Trial last updated 04/29/2016 - 10:38am.

  6. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... or partially matched UCB unit with >/= 2.5 x10^7 nucleated cells/kg of recipient weight at the time of cryopreservation. No current ... . Prior allogeneic or autologous hematopoietic stem cell transplant in the last 6 months. Patients who are taking ...

    Clinical Trial last updated 06/03/2016 - 2:54pm.

  7. About Bone Marrow Failure

    ... bone marrow .  It is the "factory" that makes blood cells.  Bone marrow contains special cells called stem cells . These blood-forming stem cells grow and mature into the three ...

    Page last updated 07/01/2013 - 4:51pm.

  8. PNH 101: Understanding Diagnosis and Treatment

    ... a bone marrow failure disease that causes red blood cells to break apart. Doctors call this process hemolysis . This occurs ... eculizumab , immunosuppressive drug therapy , stem cell transplantation, and supportive therapies like blood transfusions. ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  9. PNH 101: Understanding Diagnosis and Treatment

    ... a bone marrow failure disease that causes red blood cells to break apart. Doctors call this process hemolysis . This occurs ... eculizumab , immunosuppressive drug therapy, stem cell transplantation, and supportive therapies like blood transfusions. ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  10. Kathryn (Kate) Bauer, Retired MDS Patient Living Life to the Fullest Since Transplant

    ... and it showed something was off with my white and red blood cells. I had a repeat blood test in September and it improved slightly, but my ... as my primary caregiver. In January 2011, I received a stem cell bone marrow transplant from an unrelated donor from the ...

    Patient Chronicle last updated 07/23/2015 - 9:38am.